We help develop, evaluate, and optimize (bio)chemical processes

    Our proven methodology combines our/your expertise, well-targeted experiments, and predictive simulation to solve the biggest challenges in (bio)process development.

Your Process Secured and Optimized… It’s a Fact!

Our combined offering

Proxima Software Suite

Proxima Ionic
Design chromatographic processes
Proxima Basic design
Drawprocess diagrams and establish mass/heat balances
Proxima eval
Perform economic and environmental evaluation
Proxima Multistep
Describe your multistep synthesis within a chemist-friendly interface

Consulting

  • Improve process performances such as yield, productivity, sustainability
  • Optimize experimental plans
  • Improve process understanding
  • Develop mechanistic models
  • Perform simulations as a service
  • Determine the design space
  • Troubleshoot existing processes

A Result oriented partner

Polypeptide Group

Reduced solvent consumption by 57% in peptide solid phase synthesis. Read more

Aker Biomarine

Doubled productivity of a multi-column ion exchange chromatographic process with increased purity. Read more

Fareva

Re-established an antibiotic purification process that failed delivering the target purity following a change in raw material. Read more

GSK

Reduced experimental work by 4 compared to DoE for an oligonucleotide ion exchange process, while getting much more knowledge. Read more


They trust us

They speak about us


Recent News

New leadership, shared ambition

  • March 06, 2025
Nearly six years ago, we joined the Ypso-Facto journey, eager to contribute and learn from a company driven by science and innovation...

Time flies like an arrow…

  • February 18, 2025
40 years have gone by since I graduated, 30 years since I created Novasep and 10 years since I created Ypso-Facto. At Ypso-Facto...

Events

Pharma’s Journey to Digital Manufacturing and Supply

  • August 28, 2025
We are pleased to announce that our team will take part in the ISPE DACH Workshop 2025 “Pharma’s Journey to Digital Manufacturing and Supply” , held from 15–17 September 2025 at Roche, in Basel...

SECF Sustainable pharmaceutical Industry

  • July 02, 2025
Ypso-Facto is pleased to take part in the SECF Sustainable Event 2025  in Nancy. Lucrèce Nicoud , co-CEO at Ypso-Facto, will be speaking during Session 3: Process Improvement & Intensification...

Latest publications

mAb production kinetics in CHO batch culture: exploring extracellular and intracellular dynamics

  • August 13, 2025
  • by Ypso-Facto
We are pleased to announce that  Alejandro Avilan Garzon, PhD , doctoral researcher conducting his PhD work at Ypso-Facto, has recently published part of his research in  Frontiers in Bioengineering and Biotechnology , in collaboration with our colleague  David Pfister . The study investigates key aspects of monoclonal antibody (mAb) production in CHO batch cultures, combining extracellular and intracellular data to gain a deeper understanding of process dynamics. This work contributes to our ambition to apply Ypso-Facto’s proven DSP methodology... Read more

Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.

Learn more

Contact Us
© Ypso-Facto 2014 - Powered by Ealys | Legal Information